Shandong Weigao Group Medical Polymer Company Limited (Weigao Group) has issued a notice convening its board of directors for 25 August 2026. The meeting agenda includes:

• Approval and publication of the unaudited consolidated results for the six months ended 30 June 2026. • Consideration of an interim dividend declaration and payment, if any.

The announcement, dated 27 July 2026, lists the current board composition as four executive directors (Long Jing, Cong Rinan, Lu Junqiang and Wang Daoming), two non-executive directors (Chen Lin and Tang Zhengpeng) and four independent non-executive directors (Li Guohui, Meng Hong, Li Qiang and Sun Heng).

Results and dividend details will be disclosed following the board’s deliberations on the specified date.